Killer T cells (blue) attack cancer cells (yellow). Recent research reveals key insights into how a killer T cell quickly releases one target cell and moves onto another target. Cytotoxic T cells, ...

Scientists have discovered a previously unknown type of immune cell that develops in people who successfully fight off cancer. Unlike other killer T cells, these home in on multiple cancer-associated ...

Invariant natural killer T (iNKT) cells represent a distinctive subset of lymphocytes that bridge the innate and adaptive immune systems. Characterised by a semi‐invariant T cell receptor (TCR) and ...

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive malignancy most frequently involving the nasal cavity and upper aerodigestive tract, although it may present in other extranodal ...

Scientists discovered a relationship between the immune system's killer T cells and the body's sympathetic stress response ('fight-or-flight') in varying cancer types in mouse and human tissue samples ...

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. Now ...

In the ever-evolving world of cell therapy, researchers often turn to T cells—a type of white blood cell—to transform the way we treat cancer. This is true for CAR T therapy, a modern cancer ...

There are instances where killer T cells—which are meant to precisely remove virus-infected cells—malfunction like overheated engines, attacking even healthy cells and damaging tissues. A KAIST ...